Recent Price Moves Of Shares: Abbott Laboratories (ABT), Union Pacific Corporation (UNP)

Cowen and Company set a $68.00 price objective on Abbott Laboratories (NYSE:ABT) in a research report report published on Thursday, October 19th. The brokerage now has a buy rating on the healthcare product maker's stock.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. The stock of Abbott Laboratories (NYSE:ABT) has "Equal-Weight" rating given on Tuesday, July 11 by Morgan Stanley.

In the market the company is trading unchanged from yesterday's close of 54.29.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter. Zacks Investment Research cut shares of Abbott Laboratories from a buy rating to a hold rating in a research note on Tuesday, September 26th. October 19 investment analysts at BMO Capital left the company rating at "Neutral" but moved up the price target from $56.00 to $59.00. There are brokerage firms with lower targets than the average, including one setting a price target of $47.

The price of Abbott Laboratories (NYSE:ABT) over the past year has increased 37.30% while the S&P 500 has increased 20.80%. 607,744 shares of the company's stock were exchanged.

Abbott Laboratories (NYSE:ABT) touched its 1-Year High price of $56.69 on 10/23/17 and its 1-Year Low price of $37.38 on 12/01/16. The stock has a market capitalization of $94.34 billion, a price-to-earnings ratio of 76.05 and a beta of 1.06. The stock is now moving below its 20-Day Simple Moving Average of -1.39% with a 50-Day Simple Moving Average of 2.85 percent.

The collective rating of 2 for Abbott Laboratories (NYSE:ABT) also leans strongly towards the neutral end of the spectrum.

For the current quarter, 18 analysts are projecting a mean EPS of $0.73/share. Abbott Laboratories had a net margin of 8.37% and a return on equity of 14.50%.

Abbott Laboratories (NYSE:ABT) last announced its quarterly earnings results on Wednesday, October 18th. The healthcare product maker reported $0.66 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.65 by $0.01.

The company's ATR (Average True Range) is 2.06.

ILLEGAL ACTIVITY WARNING: This news story was first posted by Week Herald and is the property of of Week Herald. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of U.S. & worldwide copyright legislation.

The company declared a dividend for shareholders to be paid on Wednesday the 15th of November 2017. Investors of record on Friday, October 13th will be issued a dividend of $0.265 per share. The ex-dividend date will be on Thursday October 12th, 2017. Volume is the basic fuel of the market since stocks move up or down in price only when shares are trading hands. This will give analytical advantage to a shorter-term trader since it pursues the price more intimately, and consequently produces less "lag" as comparison to the longer-term moving average. Following the transaction, the insider now directly owns 221,488 shares in the company, valued at $10,963,656.

In related news, insider Jaime Contreras sold 52,700 shares of the stock in a transaction on Friday, September 22nd. The shares were sold at an average price of $51.97, for a total transaction of $2,738,819.00. The disclosure for this sale can be found here.

Looking into last 5 trades, the stock observed a return of nearly -3.19%. The other 4 are split, though not evenly, between analysts who think you should buy its stock versus those who think you should sell it. Cambridge Inv Advsrs holds 0.13% in Abbott Laboratories (NYSE:ABT) or 177,127 shares. St. Louis Trust Co lifted its holdings in Abbott Laboratories by 0.4% in the second quarter. For the long-term approach of trading or also can for short period of time, 200 days MA can also help to get idea about trading, ABT has 17.10% which indicates Bullish trends and this can also make isolating trends easier. Iowa-based Cambridge Investment Advisors has invested 0.13% in Abbott Laboratories (NYSE:ABT). (NYSE:LL) has a market cap of $990.25 million and over the last 12 months, LL has risen by 88.15%. Sanders Morris Harris LLC now owns 4,986 shares of the healthcare product maker's stock worth $242,000 after purchasing an additional 16 shares during the period. Alpha Windward LLC boosted its stake in Abbott Laboratories by 0.6% in the 2nd quarter.

The company now has an insider ownership of 0.5 Percent and Institutional ownership of 74 Percent.

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare.

Like this


31 October 2017
Google Docs error locks out users
Google hasn't said anything about this issue at this point in time so it's unclear what's the reason behind this bug. Numerous users reporting the issue work in media, and the issue occurred for Fortune editors on Tuesday morning.

31 October 2017
NYPD detectives accused of kidnapping, raping woman
Friends later took the woman to Maimonides Medical Center, where a rape kit allegedly tested positive for the detectives' DNA. They then allegedly told the woman they were "freaks" and that they wouldn't arrest her if she had sex with them.

31 October 2017
Brain Scans May Help Identify People With Suicidal Thoughts
But using brain imaging technology, scientists were able to predict with 94 per cent accuracy who was seriously suicidal. This study included 17 people with known suicidal tendencies and a control group of 17 people without such tendencies.

31 October 2017
CBI files Vyapam scam chargesheet, CM Shivraj Singh Chouhan gets clean chit
CBI said that all the five excel files in the pen drive provided by Prashant Pandey were created or modified after 18 July 2013. Most accused were operating from state capital Bhopal, Indore, Ujjain, Shahdol, Ratlam, and Sagar in Madhya Pradesh .

31 October 2017
BlackRock Municipal Income Trus (NYSE:BFK) Experiences Light Trading Volume
Janney Montgomery Scott LLC bought a new stake in Blackrock Taxable Municipal Bond Trust in the second quarter worth $204,000. Stifel Financial Corp lifted its position in shares of Blackrock Municipal Income Trust by 1.0% in the 2nd quarter.

31 October 2017
Neelamani N Raju to be Karnataka's first woman police chief
The appointment of Raju comes as a boost to women police officers in the state and heralding a new outlook in the police outlook. It was speculated that the appointment of Chandra as the police force chief could have helped the party in an election year.

31 October 2017
Delhi: School bus catches fire, students evacuated
The bus was taking students towards south Delhi from Kendriya Vidyalaya number 3 in Delhi Cantonment. It is suspected to have been caused due to a technical glitch in the engine, the police said.

31 October 2017
Mobile US, Inc. (TMUS) Ownership Decreased by Korea Investment Corp
The Wireless communications provider reported $0.63 EPS for the quarter, beating analysts' consensus estimates of $0.46 by $0.17. The value of the investment in T-Mobile US, Inc. increased from $7,156,000 to $7,709,000 increasing 7.7% quarter to quarter.

31 October 2017
America Apartment Communities, Inc. (MAA) Downgraded by JMP Securities to Market Perform
Suntrust Robinson downgraded Mid-America Apartment Communities Inc (NYSE:MAA) on Friday, January 22 to "Neutral" rating. Mid-America Apartment Communities (NYSE:MAA) last released its quarterly earnings results on Wednesday, October 25th.

31 October 2017
Scana CEO to step down after failed nuclear project
The leader of a second SC utility involved in a failed $9 billion project to build two nuclear reactors is stepping aside. SCANA CEO Kevin Marsh and Senior VP Stephen Byrne announced their retirement in a statement to the media.